CONCLUSIONS: The PACE Australia program improved GPs' asthma management practices and led to improvements in some vital patient outcomes. Trial registration: Australian Fresh Zealand Clinical Trials Registry ACTRN12607000067471.
PMID: 21978349 [PubMed - in action] (Source: Med J Aust) More information: More infos...
Tag Archives: trial
Improving paediatric asthma outcomes in primary health care: a randomised controlled trial.
Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial
Background:
Fluticasone furoate (FF) is a novel extended-acting inhaled corticosteroid (ICS). This double-blind, placebo-controlled randomized study evaluated the efficacy and safety of FF 200 mcg or 400 mcg once daily, either in the morning or in the evening, and FF 200 mcg twice daily (morning and evening), for 8 weeks in patients with persistent asthma.
Methods:
Asthma patients maintained on ICS for [greater than or equal to]3 months with baseline morning forced expiratory volume in one second (FEV1) 50-80% of predicted normal value and FEV1 reversibility of [greater than or equal to]12% and [greater than or equal to]200 ml were …
Allergy Vaccine Passes Phase II Clinical Trial
The trial discovered that a regimen from the vaccine enhanced eye allergy responses by 30 % and skin responses by 54 percent. More details: Full article...
Tags: eye allergy, phase, trial, Health, clinical trial…
The spanish language Vaccine Risk Turning Aids Right Into A Minor Herpes-Like Chronic Infection
A Phase I human study utilizing a vaccine known as MVA-B has accomplished an immunological response in 92% of healthy volunteers against Aids, with 85% of these maintaining immunity not less than 12 several weeks. Scientists in the Consejo Superior p Investigaciones CientÃficas (CSIC), Madrid, Gregorio Marañón Hospital, Madrid and ClÃnic Hospital, Barcelona, reported the outcomes from the trial within the journals Vaccine and Journal of Virology... (Source: Health News from Medical News Today)
MedWorm Sponsor Message: Please pay attention to this plea of support for the health workers in Bahrain. #FreeDoctors
More details: More infos...
Tags: Health…,
FENO Measurement May Guide Bronchial asthma Management in PregnancyFENO Measurement May Guide Bronchial asthma Management during pregnancy
Inside a randomized trial, bronchial asthma exacerbations throughout pregnancy were considerably reduced having a validated treatment formula using fraction of blown out nitric oxide supplement. Medscape Medical News (Source: Medscape Today Head lines) More details: Informations...
Tags: measurement, trial, pregnancy, asthma exacerbations, Health…
Formula Enhances Bronchial asthma Care during pregnancy (CME/CE)
(MedPage Today) -- The amount of bronchial asthma exacerbations was divide in two among women that are pregnant when treatment choices were led by dimensions from the fraction of blown out nitric oxide supplement, a randomized trial found. (Source: MedPage Today Allergy) More details: More infos...
Tags: Health, CME, treatment decisions, trial, fraction, asthma…
Health-Related Quality of Existence within the Gender, Race, And Clinical Experience Trial
Conclusion. HRQoL enhanced in most sex and racial/ethnic groups. Sex-based and race-based variations in enhancements in FAHI subscales may provide understanding of subtle variations of Aids-1 and treatment on HRQoL in various populations. (Source: Clinical and Developmental Immunology) More details: Check this...
Tags: Health, gender race, trial, Clinical, HIV, racial ethnic groups…
Omalizumab reduces frequency of bronchial asthma exacerbations in youngsters
Busse WW, Morgan WJ, Gergen PJ, Mitchell HE, Gern JE, Liu AH, et al. Randomized trial of omalizumab (anti-IgE) for bronchial asthma in inner-megalopolis children. N Engl J Mediterranean 2011364:1005-15. (Source: The Journal of Pediatric medicine) More details: Check this...
Horizon scanning: Efficacy of lebrikizumab in patients with asthma
Source: NEJM
Area: News
This randomised, double blind, placebo controlled multicentre trial aimed to determine whether treatment with lebrikizumab would improve the control of asthma. Lebrikizumab is a monoclonal antibody that specifically binds to interleukin-13 (IL-13) and inhibits its function. IL-13 is thought to contribute to many of the main features of asthma. Patients with asthma that was inadequately controlled with inhaled glucocorticoid therapy were randomised (1:1 ratio) to receive lebrikizumab (250mg; n =107) or placebo (n =112) subcutaneously once a month. The researchers examined all enrolled patients as a collection and then stratified the …
- Q&A: Is it okay to wear contacts if you have allergies ?
- Q&A: What is the best over the counter medicine to take for sinus allergies?
- What is good for runny nose and nasal congestion probably due to allergies?
- Can an old air conditioner trigger allergies?
- Can kissing someone for half an hour cure allergies?
- Improving paediatric asthma outcomes in primary health care: a randomised controlled trial.
- Obese Mothers Put Children at Higher Risk of Asthma
- Home-based educational interventions for children with asthma.
- Aspirin Desensitization: A "Lifechanger" For Patients With Aspirin And NSAID Allergies; Cardiovascular Disease
- New Study Aims to Cure Food Allergies
-
Lillie: I am currently having desensitisation injections (...
-
Eye Floaters Treatment: Eye floaters are the most annoying health issue yo...
-
Gary: LET ME ADD SOME CORRECTIONS TO MY PREVIOUS MESSAGE...
-
-
Tyrell Boresha: L-arginine makes me feel young again...